190 related articles for article (PubMed ID: 34715128)
21. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.
Xu S; Khoo S; Dang A; Witt S; Do V; Zhen E; Schaefer EM; Cobb MH
Mol Endocrinol; 1997 Oct; 11(11):1618-25. PubMed ID: 9328344
[TBL] [Abstract][Full Text] [Related]
23. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.
Caunt CJ; Sale MJ; Smith PD; Cook SJ
Nat Rev Cancer; 2015 Oct; 15(10):577-92. PubMed ID: 26399658
[TBL] [Abstract][Full Text] [Related]
24. The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation.
Boyd SD; Calvo JS; Liu L; Ullrich MS; Skopp A; Meloni G; Winkler DD
J Biol Chem; 2019 Feb; 294(6):1956-1966. PubMed ID: 30530491
[TBL] [Abstract][Full Text] [Related]
25. Human cytoplasmic copper chaperones Atox1 and CCS exchange copper ions in vitro.
Petzoldt S; Kahra D; Kovermann M; Dingeldein AP; Niemiec MS; Ådén J; Wittung-Stafshede P
Biometals; 2015 Jun; 28(3):577-85. PubMed ID: 25673218
[TBL] [Abstract][Full Text] [Related]
26. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.
Eblen ST; Slack JK; Weber MJ; Catling AD
Mol Cell Biol; 2002 Sep; 22(17):6023-33. PubMed ID: 12167697
[TBL] [Abstract][Full Text] [Related]
27. The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.
Yamashita S; Tai P; Charron J; Ko C; Ascoli M
Mol Endocrinol; 2011 Jul; 25(7):1211-22. PubMed ID: 21527500
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy.
Daouti S; Wang H; Li WH; Higgins B; Kolinsky K; Packman K; Specian A; Kong N; Huby N; Wen Y; Xiang Q; Podlaski FJ; He Y; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2009 Mar; 69(5):1924-32. PubMed ID: 19244124
[TBL] [Abstract][Full Text] [Related]
29. Molecular and biochemical characterization of a unique mutation in CCS, the human copper chaperone to superoxide dismutase.
Huppke P; Brendel C; Korenke GC; Marquardt I; Donsante A; Yi L; Hicks JD; Steinbach PJ; Wilson C; Elpeleg O; Møller LB; Christodoulou J; Kaler SG; Gärtner J
Hum Mutat; 2012 Aug; 33(8):1207-15. PubMed ID: 22508683
[TBL] [Abstract][Full Text] [Related]
30. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Bissonauth V; Charron J; Khavari PA
Dev Cell; 2007 Apr; 12(4):615-29. PubMed ID: 17419998
[TBL] [Abstract][Full Text] [Related]
31. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR; Oliver KE; Farley JH
Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
[TBL] [Abstract][Full Text] [Related]
32. A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.
Wu PK; Hong SK; Veeranki S; Karkhanis M; Starenki D; Plaza JA; Park JI
Mol Cell Biol; 2013 Oct; 33(20):4051-67. PubMed ID: 23959801
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of the copper-dependent turnover of the copper chaperone for superoxide dismutase.
Caruano-Yzermans AL; Bartnikas TB; Gitlin JD
J Biol Chem; 2006 May; 281(19):13581-13587. PubMed ID: 16531609
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways.
Rastogi R; Jiang Z; Ahmad N; Rosati R; Liu Y; Beuret L; Monks R; Charron J; Birnbaum MJ; Samavati L
J Biol Chem; 2013 Nov; 288(47):33966-33977. PubMed ID: 24126911
[TBL] [Abstract][Full Text] [Related]
35. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in
Wu PK; Hong SK; Park JI
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674184
[TBL] [Abstract][Full Text] [Related]
36. An essential role of N-terminal domain of copper chaperone in the enzymatic activation of Cu/Zn-superoxide dismutase.
Fukuoka M; Tokuda E; Nakagome K; Wu Z; Nagano I; Furukawa Y
J Inorg Biochem; 2017 Oct; 175():208-216. PubMed ID: 28780408
[TBL] [Abstract][Full Text] [Related]
37. Activation of Cu,Zn-superoxide dismutase in the absence of oxygen and the copper chaperone CCS.
Leitch JM; Jensen LT; Bouldin SD; Outten CE; Hart PJ; Culotta VC
J Biol Chem; 2009 Aug; 284(33):21863-21871. PubMed ID: 19542232
[TBL] [Abstract][Full Text] [Related]
38. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
Voisin L; Julien C; Duhamel S; Gopalbhai K; Claveau I; Saba-El-Leil MK; Rodrigue-Gervais IG; Gaboury L; Lamarre D; Basik M; Meloche S
BMC Cancer; 2008 Nov; 8():337. PubMed ID: 19014680
[TBL] [Abstract][Full Text] [Related]
39. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.
Rae TD; Schmidt PJ; Pufahl RA; Culotta VC; O'Halloran TV
Science; 1999 Apr; 284(5415):805-8. PubMed ID: 10221913
[TBL] [Abstract][Full Text] [Related]
40. Copper chaperone-dependent and -independent activation of three copper-zinc superoxide dismutase homologs localized in different cellular compartments in Arabidopsis.
Huang CH; Kuo WY; Weiss C; Jinn TL
Plant Physiol; 2012 Feb; 158(2):737-46. PubMed ID: 22186608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
